We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Resveratrol-Like Compound Offers Potential Natural Protection Against Radiation

By LabMedica International staff writers
Posted on 16 May 2011
Amid ongoing worries about radiation exposure from the Fukushima nuclear power plant in Japan, scientists are reporting that a compound similar to the antioxidant resveratrol could protect against radiation sickness. More...


The report's findings were published in April 14, 2011, in the journal ACS Medicinal Chemistry Letters. Dr. Michael Epperly, Dr. Kazunori Koide, and colleagues from the University of Pittsburgh (PA, USA) explained in their article that radiation exposure, either from accidents or from radiation therapy, can make people ill; higher doses could even cause death.

The US Food and Drug Administration (FDA) are currently assessing a drug for its ability to protect against radiation sickness, but it is difficult to make in large amounts, and the drug has side effects that prevent its use for cancer patients. To overcome these problems, the researchers evaluated whether resveratrol could protect against radiation injuries.

The investigators found that resveratrol protected cells in flasks but did not protect mice from radiation damage. However, the similar natural product called acetyl resveratrol did protect the irradiated mice. It also can be generated easily in large quantities and given orally. The authors cautioned, however, that it has not yet been determined whether acetyl resveratrol is effective when orally administered.

Related Links:

University of Pittsburgh




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.